Neuralink, a company developing brain-computer interfaces (BCIs), announced progress in linking human brains to machines. It recently confirmed that three individuals received experimental implants, with all devices operating as expected. These implants aim to help people with spinal cord injuries and neurological disorders regain certain functions. Since the first implant was performed a year ago, Neuralink has improved its technology by increasing the number of electrodes, boosting data transfer rates, and extending battery life. The company plans to conduct 20 to 30 more implant procedures by the end of the year, aiming to broaden the technology’s medical applications. Other companies, including Synchron and Blackrock Neurotech, are also working on BCIs to aid patients with severe physical limitations.

Neuralink uses robotic systems to precisely insert flexible electrodes into the brain, a technique considered innovative by some researchers. However, its potential advantages over existing methods remain unclear. Other companies conducting trials use different implantation techniques, which might carry fewer risks. Recent findings indicate that BCIs have already helped individuals with ALS improve their communication abilities. Additionally, over 45 clinical trials are underway to explore how BCIs might treat brain-related disorders and restore lost abilities. Despite technical challenges and potential risks, BCIs are viewed as promising tools for improving life quality in people with paralysis and other serious health issues.